Infant with diabetes – a diagnostic challenge for paediatricians

Common symptoms of diabetes in newborns and infants are uncharacteristic, what often leads to the delay in diagnosis and implementation of proper treatment. Diabetes is rare disease in this life period, but paediatricians should remember about checking glucose level in unwell babies. Children with neonatal diabetes are characterised by low birth weight, significant hyperglycaemia, often with concomitant metabolic acidosis. Hyperglycaemia diagnosed in the neonatal period requires the immediate implementation of insulin therapy, which is essential for proper development and growth of the child.
This paper describes a 30-day old boy with permanent neonatal diabetes and all diagnostic and therapeutic difficulties before the final diagnosis was made.

REFERENCES (13)

Zalecenia kliniczne dotyczące postępowania u chorych na cukrzycę 2020. Stanowisko Polskiego Twarzystwa Diabetologicznego. Diabetologia Praktyczna 2020; 6: 1.

Google Scholar

Tamaro P, Flanagan E, Zadek B, et al. Kir 6.2 mutation causing severe functional effects in vitro produces neonatal diabetes without the expected neurological complications. Diabetologia 2008; 51: 801-810.

Google Scholar

Lemelman MB, Letourneau L, Greeley SAW. Neonatal diabetes mellitus: an update on diagnosis and management. Clin Perinatol 2018; 45: 41-59.

Google Scholar

Rubio-Cabezas O, Klupa T, Malecki MT; CEED3 Consortium. Permanent neonatal diabetes mellitus – the importance of diabetes differential diagnosis in neonates and infants. Eur J Clin Invest 2011; 41: 323-333.

Google Scholar

Antosik K, Borowiec M. Genetic factors of diabetes. Arch Immunol Ther Exp (Warsz) 2016; 64 (Suppl 1): 157-160.

Google Scholar

Sagen JV, Raeder H, Hathout E, et al. Permanent neonatal diabetes due to mutation in KCNJ 11 encoding Kir 6.2: patent characteristics and response to sulfonylurea therapy. Diabetes 2004; 53: 2713-2718.

Google Scholar

Gloyn AL, Pearson ER, Antcliff JF. Activing mutation in the gene encoding the ATP-sensitive potassium-chanel subunit Kir 6.2 and permanent neonatal diabetes. N Engl J Med 2004; 350: 1838-1849.

Google Scholar

Carmody D, Pastore AN, Landmeier KA, et al. Patients with KCNJ11-related diabetes frequently have neuropsychological impairments compared with sibling controls. Diabet Med 2016; 33: 1380-1386.

Google Scholar

Noczyńska A, Zubkiewicz-Kucharska A, Salamonowicz B. Three-year observation of permanent neonatal diabetes. Pediatr Endocrinol Diabetes Metab 2010; 16: 50-54.

Google Scholar

10.

Pearson ER, Flechtner I, Njølstad PR, et al. Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations. N Engl J Med 2006; 355: 467-477.

Google Scholar

11.

Ashcroft FM. The Walter B. Cannon Physiology in Perspective Lecture. ATP-sensitive K+ channels and disease: from molecule to malady. Am J Physiol Endocrinol Metab 2007; 293: E880-E889.

Google Scholar

12.

Kosiak W, Swieton D, Piskunowicz M. Sonographic inferior vena cava/aorta diameter index, a new approach to the body fluid status assessment in children and young adults in emergency ultrasound – preliminary study. Am J Emerg Med 2008; 26: 320-325.

Google Scholar

13.

ISPAD’s Clinical Practice Consensus Guidelines 2018.

Google Scholar

SUBMIT YOUR PAPER